摘要
目的:评价3种给药方案治疗冠心病心绞痛的经济学效果。方法:按不同治疗方案分为硝酸甘油注射液(A组,n=30)、单硝酸异山梨酯注射液(B组,n=30)、参芎注射液(C组,n=30)3组,疗程均为14d。考察3组疗效及不良反应,并进行药物经济学分析。结果:A、B、C组总有效率分别为83.3%、76.7%、66.7%,差异无统计学意义;A、B、C组不良反应发生率分别为43.3%、23.3%、0.0%,差异有统计学意义(P<0.001);A、B、C组总成本分别为(119.67±3.75)、(329.15±9.53)、(1109.90±254.07)元,差异有统计学意义(P<0.01)。结论:A组与B组不良反应发生率较高,但这些反应均不严重,且输液结束后即可消失,权衡利弊仍选A组为最佳方案,B组其次,C组最差。
OBJECTIVE: To evaluate the economic efficacy of 3 therapeutic regimens in the treatment of angina pectoris of patients with coronary artery disease(CAD). METHODS: The patients were assigned to receive nitroglycerin injection (Group A, n = 30), isosorbide mononitrate injection(Group B, n = 30) or shenxiong injection(Group C, n = 30) for 14 days. The clinical efficacy and adverse drug reactions(ADR) in the 3 groups were observed and the pharmacoeconomic analysis was carried out. RESULTS: The total effective rates of A, B and C groups were 83.3%, 76.7% and 66.7%, respectively, showing no significant difference among the 3 groups; the incidences of ADR of A, B and C groups were 43.3%, 23.3% and 0.0%, respectively, manifesting sharp significant difference(P〈0.001) ; the total costs were( 119.67 ± 3.75) yuan, (329.15± 9.53) yuan and ( 1 109.90±254.07) yuan, respectively, presenting significant differences among the 3 groups( P 〈 0.01). CONCLUSION : The incidences of ADR of groups A and B were higher but mild, which disappeared after completion of drug infusion. Considering the merits and demerits, Group A is regarded as the optimal one, followed by Group B, and Group C is the worst one.
出处
《中国药房》
CAS
CSCD
北大核心
2009年第32期2487-2489,共3页
China Pharmacy
关键词
最小成本分析
心绞痛
硝酸甘油注射液
单硝酸异山梨酯注射液
参芎注射液
Costminimization analysis
Angina pectoris
Nitroglycerin injection
Isosorbide mononitrate injection
Shenqiong injection